Earlier this year, the Food and Drug Administration approved a new human papillomavirus test that allows for self-collection ...

Human papillomavirus (HPV) is a common viral infection typically transmitted through intimate contact, primarily during ...

Recent medical studies reveal that asymptomatic sexually transmitted infections (STIs) present a growing public health ...

A new study provides good evidence that the human papillomavirus (HPV) vaccine may be achieving its goal of slashing ra ...

"The HPV vaccine prevents cervical cancer by protecting against the high-risk HPV types," cancer researcher Ashish A.

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than ...

The cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improve when ...

While the HPV vaccine is often marketed in Iowa toward women, a health care professional says it’s important that young ...

Researchers found a reduction in cervical cancer mortality in women under the age of 25, which is likely due to the introduction of the HPV vaccine.

Cervical cancer deaths have plunged dramatically among women under age 25, and researchers at MUSC Hollings Cancer Center ...

This interesting study presents valuable information on how human cytomegalovirus (HCMV) infection disrupts the activity of the TEAD1 transcription factor, leading to widespread chromatin alterations.

Dr. Carrie Sopata, a gynecologist at UVA Health, said women can opt for the new procedure to avoid a speculum exam.